Call for information/EOI for neutralising antibodies.
Estimated value
£1
goods
Awarded value
—
Suppliers
0
Lots
1
0 awarded
Published
05 Oct 2021
This is a preliminary market engagement notice
Map the supplier landscape and document your shortlist before opening the tender. The market simulation produces a defensible audit record you can attach to your procurement file.
Description
DHSC invites suppliers to submit an EOI on neutralising antibodies andbinding site, clinical trials on efficacy, safetyfor preventing or treating COVID-19infection, dose&frequency, formats/routesfor administering to patients, monitoringadverse affects, efficacy against SARSCoV-2 variants, supply availability for 2021-2022 and future years and plans forregulatory approval in the UK, if not yetapproved.
Scope
- Reference
- ocds-h6vhtk-02e853
- Total value
- £1 excluding VAT
- Commercial tool
- Standalone contract
- Main category
- goods
- Contract locations
- UK